Multi-center phase II clinical trial of humanized anti-epidermal factor receptor monoclonal antibody h-R3 combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma

Zhonghua zhong liu za zhi [Chinese journal of oncology]

Volumn 29, Issue 3, 2007, Pages 197-201

  Huang, Xiao dong ^a   Yi, Jun lin ^a   Gao, L ^a   Xu, Guo zhen ^a   Jin, Jing ^a   Yang, Wei zhi ^a   Lu, Tai xiang ^a   Wu, Shao xiong ^a   Wu, Ren rui ^a   Hu, Wei han ^a   Xie, Wei chang ^a   Han, Fei ^a   Gao, Yuan hong ^a   Gao, Jian ming ^a   Pan, Jian ji ^a   Chen, Chuan ben ^a   Lang, Jin yi ^a   Li, Tao ^a   Dong, Y ^a   Fu, Yu bing ^a   Fan, Lin ^a   Li, Bo sen ^a   Li, Jing ^a   Wang, Xiao huai ^a   Chen, Bing xu ^a   Gao, Xian shu ^a   Zhang, Ping ^a   Wu, Xiang wei ^a   Hu, Bing qiang ^a   more..

^a CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEVER; HUMAN; HYPOTENSION; IMMUNOLOGY; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NASOPHARYNX TUMOR; PATHOLOGY; PHASE 2 CLINICAL TRIAL; QUALITY OF LIFE; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REMISSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; FEVER; HUMANS; HYPOTENSION; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; QUALITY OF LIFE; RADIOTHERAPY; RECEPTOR, EPIDERMAL GROWTH FACTOR; REMISSION INDUCTION;

EID: 42949095528     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)